FDA: J&J delayed reporting insulin pump problems

Courtesy Seattle Post-Intelligencer: Health and Fitness  Wed, 01/11/2012 - 11:47

FDA: J&J delayed reporting insulin pump problems The FDA says inspectors found Animas never reported or delayed reporting on patients hospitalized with dangerously high blood sugar, respiratory failure and coma, and a life-threatening complication called diabetic ketoacidosis.


 

More related items

FDA Panel Votes in Favor of Weight Loss Pill Qnexa
An FDA advisory committee has reversed an earlier decision and voted overwhelmingly in favor of approving the weight loss pill Qnexa.

Diabetes, High BP During Pregnancy Increase...
When a woman has high blood pressure or high blood sugar levels during pregnancy, this may help predict her chances of developing heart disease perhaps as early as middle age, a new study...

Drug-Eluting Stent Approved for Diabetics
(MedPage Today) -- The FDA has approved the Resolute Integrity drug-eluting stent, the first such stent to carry an indication for use in diabetics with coronary artery disease, according to...

Numi's Bouquet Bamboo Gift Set with Clear Teapot and...

Mania By Giorgio Armani For Men. Eau De Toilette...
Mania Was Created For The Man Seeking A Discreet, Elegant, And Classic Signature Scent. The Classical Freshness Of Mania Is Built Around A Sensual Amber-woody Accord That Brings To Mind Warm...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com